• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vaneck Biotech ETF (NQ: BBH )

    170.81 +1.18 (+0.70%)
    Official Closing Price Updated: 4:15 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Vaneck Biotech ETF

    VanEck Announces Year-End Distributions for VanEck Equity ETFs
    From VanEck
    Via Business Wire
    Time For Gilead Sciences-Heavy ETFs?
    Gilead Sciences has underperformed the broader market this year by a hefty margin. 
    Via Talk Markets
    Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
    U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval of... 
    Via Benzinga
    Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
    A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug. 
    Via Benzinga
    New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
    New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this... 
    Via Benzinga
    Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
    In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating... 
    Via Benzinga
    FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
    Via Benzinga
    VanEck Launches Robotics ETF (IBOT)
    From VanEck
    Via Business Wire
    US Judge Weighs Nationwide Ban On Abortion Pills
    U.S. District Judge Matthew Kacsmaryk questioned President Joe Biden's administration lawyers on whether the federal regulatory approval of the abortion pill mifepristone was proper. The judge is... 
    Via Benzinga
    FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
    Via Benzinga
    3 Best Funds for Aggressive Investors
    These are the three best funds for aggressive investors. ETFs like BUG, RYT, and BBH can make great investments in the rest of the year. 
    Via InvestorPlace
    Progenity Is Unlikely to Live Up to Its IPO Hype
    Progenity went public in June 2020. Eighteen months later, PROG stock has lost 83% of its value. Is there any hope for this fading biotech? 
    Via InvestorPlace
    Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money
    With an economic hurricane on the horizon, investors are searching for alternative investment paths and profitable places to invest in. 
    Via InvestorPlace
    How Are Biotech ETFs Reacting To These Q3 Earnings Releases?
    There's no denying that the pandemic has opened up investment opportunities in the biotech sector by triggering a race to introduce vaccines. Let’s take a look at big biotech earnings releases to see... 
    Via Talk Markets
    Novavax Stock Is a Buy for Long-Term Investors on Its Pipeline Alone
    After the formidable run, NVAX stock has come under significant pressure, but between its pipeline and its Covid vaccine, it is a dip buy. 
    Via InvestorPlace
    Take A Look At The Top-Performing Biotech ETFs YTD
    The biotechnology sector has been grabbing the headlines on the new coronavirus vaccine and drug-related updates. The space has also kept its promise of generating returns, with the Nasdaq... 
    Via Talk Markets
    Exposures COVID-19
    Biotech ETFs To Benefit From Latest Booster Update
    Vaccine makers like Moderna and Pfizer have reasons to cheer the update with regard to the application of boosters. The U.S. government announced plans to make COVID-19 vaccine boosters available from... 
    Via Talk Markets
    Exposures COVID-19
    ETF Investing Areas to Consider for August
    There is no doubt that the second-quarter 2021 earnings season is going strong. 
    Via Talk Markets
    Moderna ETFs To Rise On Positive COVID-19 Vaccine Updates
    The competition to come up with a vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to... 
    Via Talk Markets
    Exposures COVID-19
    5 Top ETFs With Exposure To Biogen
    Here is a look at five ETFs with large exposure to Biogen shares. 
    Via Talk Markets
    5 Top ETFs With Exposure To Biogen
    For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that... 
    Via Benzinga
    Exposures Product Safety
    Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines
    The Biden administration announced support for the waiver of intellectual property protections for COVID-19 vaccines proposed by South Africa and India. Let’s take a look at ETFs that can suffer from... 
    Via Talk Markets
    Topics Intellectual Property
    Exposures COVID-19 Intellectual Property
    Moderna Stock Moves After Q1 Print: Technical Levels For The COVID-19 Vaccine Play
    Moderna Inc. (NASDAQ: MRNA) shares gapped down Thursday and have since gained back some ground. Moderna reported first-quarter earnings Thursday of $2.84 per share, beating the... 
    Via Benzinga
    Exposures COVID-19
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.